These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 18038767

  • 1. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 2. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH, Gasim Khalil EA, Theander TG, Kharazmi A, Omer SA, Ibrahim ME.
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [Abstract] [Full Text] [Related]

  • 3. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D.
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [Abstract] [Full Text] [Related]

  • 4. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S, Mandal A, Duttagupta S.
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [Abstract] [Full Text] [Related]

  • 5. Ketoconazole in antimonial unresponsive cases of Kala-azar.
    Jha TK, Singh NK, Jha S.
    J Assoc Physicians India; 1995 May; 43(5):347. PubMed ID: 9081966
    [No Abstract] [Full Text] [Related]

  • 6. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 May; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 7. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP, Thakur S, Narayan S, Sinha A.
    Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
    Kumar D, Kulshrestha A, Singh R, Salotra P.
    Antimicrob Agents Chemother; 2009 Feb; 53(2):835-8. PubMed ID: 19015344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
    Dube A, Singh N, Sundar S, Singh N.
    Parasitol Res; 2005 Jun; 96(4):216-23. PubMed ID: 15868188
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P.
    J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477
    [Abstract] [Full Text] [Related]

  • 13. Novel mechanism of drug resistance in kala azar field isolates.
    Singh N, Singh RT, Sundar S.
    J Infect Dis; 2003 Aug 15; 188(4):600-7. PubMed ID: 12898450
    [Abstract] [Full Text] [Related]

  • 14. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
    Thakur CP, Dedet JP, Narain S, Pratlong F.
    Trans R Soc Trop Med Hyg; 2001 Aug 15; 95(2):187-9. PubMed ID: 11355558
    [Abstract] [Full Text] [Related]

  • 15. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A, Seth A, Kaur S, Aneja S, Rath B, Basu S, Patel R, Dutta AK.
    Pediatr Infect Dis J; 2011 Feb 15; 30(2):180-1. PubMed ID: 20823781
    [Abstract] [Full Text] [Related]

  • 16. Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational study.
    Narayan S, Gupta AK, Singh Subhankar K, Lal CS, Singh VP, Sinha PK, Das P, Thakur CP.
    J Commun Dis; 2008 Dec 15; 40(4):273-6. PubMed ID: 19579720
    [Abstract] [Full Text] [Related]

  • 17. Antimony-induced cerebellar ataxia.
    Khalil EA, Ahmed AE, Musa AM, Hussein MH.
    Saudi Med J; 2006 Jan 15; 27(1):90-2. PubMed ID: 16432602
    [Abstract] [Full Text] [Related]

  • 18. Treatment of kala-azar in India.
    Thakur CP.
    Natl Med J India; 1992 Jan 15; 5(5):203-5. PubMed ID: 1338871
    [No Abstract] [Full Text] [Related]

  • 19. [Visceral leishmaniasis refractory to treatment: the efficacy of amphotericin B].
    Pérez Brea A, Ruiz Moreno M, Leal Orozco A, Escorihuela Esteban R, Otero Fraguas M.
    An Esp Pediatr; 1996 Feb 15; 44(2):161-3. PubMed ID: 8830578
    [No Abstract] [Full Text] [Related]

  • 20. Amphotericin B in visceral leishmaniasis.
    Jha BB.
    Indian Pediatr; 1996 Nov 15; 33(11):971. PubMed ID: 9141838
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.